Immunohistochemical (IHC) analysis of tumor tissues revealed that combined DMF and anti-PD-L1 treatment significantly increased the number of tumor-infiltrating CD8+ T cells and the level of granzyme B, demonstrating a synergistic effect in stimulating CD8+ T cell tumor infiltration and anti-tumor immunity (Fig. 6E, F). Here, CD274 is linked to neoplasm.